Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03894891
Title Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Winship Cancer Institute Atlanta Georgia 30308 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
The Tisch Cancer Institute New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field